Drug Delivery for the 21st Century

Drug Delivery for the 21st Century


Meets Drug Delivery


Inductive Power

The TargetTab™ system utilizes inductive power (no on-board batteries) and proprietary innovative smart polymer technology for the actuation and release system. We continue to advance the capabilities of wireless power for the future of digital medicine.


Real-time Monitoring

The SmartTab platform connects with a smartphone or smartwatch via bluetooth RF signal to monitor when the capsule has reached the desired location. Monitoring for statistical based therapy optimization. Real-time decision making and wireless drug delivery.


Targeted Medicine

We are developing superior drug delivery mechanisms. Using technology for an advanced drug delivery system that target's precise locations in the GI tract. When the triggering signal is sent, it releases immediately for better drug efficacy and better patient outcomes.


Increased Drug Compliance

One of the biggest problems with treatments today is compliance. With the SmartTab electronic system triggering the release, the physician knows whether the patient is adhering to the prescribed drug treatment regimen.


Lower Toxicity

By having a very specific targeted delivery system we can negate the negative side effects associated with the medicine and will be able to use lower dosages. Lower dosages means lower side effects and improved patient outcomes.


Internet of Medical Things (IoMT)

Integration with IoMT. Data can be sent into artificial intelligence and then optimize the treatment. The SmartTab platform will integrate with other systems as the future of digital health evolves.


Disruptive Biologic Delivery Technology  

InjectTab™ is an oral delivery system for biologics and large molecules. A revolutionary wireless ingestible capsule designed to replace the conventional needle and syringe.



A Clear Path to Commercialization

TargetTab™ is an ingestible capsule for wireless, targeted drug delivery. This is first application of the SmartTab Platform for Crohn's and other GI related diseases. 



Groundbreaking Tech Findings

SmartTab recently published “Advancing High Tech Drug Delivery Systems for the Treatment of Crohn’s Disease” in Inflammatory Bowel Diseases (IBD) Journal, and the Journal of Gastroenterology. A poster of distinction, as one of the top-scoring abstracts at the Crohn's and Colitis Congress 2021.



SmartTab Publishes Groundbreaking Tech Drug Delivery Findings for the Treatment of Crohn’s Disease

Press Release: The Denver-based digital medicine startup, SmartTab, published their most recent, innovative work in the IBD Journal

The SmartTab Story: Uphill and Downright Genius

A mountain-born medical revolution that will transform the pharmaceutical industry forever JUST FOUR YEARS AGO, Robert Niichel was sitting on his bike high on Vail mountain pass, staring out at the...

SmartTab Presents During J.P. Morgan 39th Annual Healthcare Conference at Digital Medicine & Medtech Showcase

For the second year, SmartTab will present at Digital Medicine & Medtech Showcase. As an innovative medical startup that’s part of Veloce Digital Health, SmartTab continues to find success in...


Leadership Team

Robert Niichel
Founder & CEO
Douglas Miller, PhD
Chief Technology Officer

25+ years of experience in the medical device; multi-national corporate R&D; 20+ years experience in active implantable devices; 5+ years in in-vitro diagnostics and pharmaceuticals; Led R&D, manufacturing, quality, and regulatory functions at VP level; 9 patents in the biomedical field; Published author; BS in Electrical Engineering; MS & PhD in Electrical/Biomedical Engineering.

Dr. Mark Brunvand
Chief Medical Officer & Clinical Director
Sacha Francois Heppell
Chief Marketing Officer